As Figure 10J shows, down-regulation of tumor-derived GLI2 leads down-regulation of PDL1, TGF-beta and IL6 in lovo cells, and it also leads down-regulation of TIM-3, PD1 and IFN-gamma in NK cell line (NK-92) (Figure 10J–10L). Here, GLI2 is linked to neoplasm.